Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Abstract: Artificial macrocycles can be convergently synthesized by a sequence of an Ugi multicomponent reaction (MCR) followed by an intramolecular Passerini MCR used to close the macrocycle. Significantly, in this work, the first intramolecular macrocyclization through a Passerini reaction is described. We describe 21 macrocycles of the size of 15-20. The resulting macrocyclic depsipeptides are model compounds for natural products and could find applications in drug discovery.
Scheme 1.
Key contributions to the use of the Passerini 3-CR in the depsipeptid synthesis and the herein described work.
Having convenient access to α-isocyano-ω-carboxylates with different size and substitution pattern, as recently described by us, we first focused here on pathway B. 22 The envisioned synthetic pathway is sketched in Scheme 2.
First, to introduce linkers of multiple chain lengths and side chains, we reacted an oxo component (aldehyde, ketone) 1 with tritylamine 2, TMSN 3 3 and a variety of α-isocyano-ω-carboxylic acid methyl esters 4 in an Ugi tetrazole MCR to yield 5. After detritylation, the potassium salt of an α-isocyano-ω-carboxylic acid 7 was coupled to the primary amine 6, followed by saponification of 9. Finally, with the help of another oxo component 10, the macrocycle was closed by a Passerini 3-CR 11. To increase diversity and to vary ring size, we synthesized eight α-isocyano-ω-carboxylate linkers 9 of different length from their commercial starting materials according to Scheme 1. While all reactions in Scheme 2 have precedence and are well described in the literature, the Passerini macrocyclization is new and required a lot of optimization, including time, solvent, and concentration (Table 1) . Surprisingly, after extensive optimization, we found that 0.01 M dilution in water was optimal. The latter aspect is unusual for the Passerini reaction, which is described as performing best in aprotic a polar solvents such as ether, THF, and DCM. 4 Cl 20% product 10% product a The reaction for compound 11.2 was used for the optimization. The additive was used based on the result we obtained previously. 22 The mixtures were allowed to first stir at rt for 24 h, followed by 24 h at 60 o C (NP = No product). The reaction highlighted had the cleanest TLC.
Scheme 2. Synthesis strategy toward artificial macrocyclic depsipeptides. The carboxylate might benefit from water in several aspects: It might enhance the solubility of the starting material carboxylate as well as the additive used. Most compounds show rotamers in the NMR spectra, and 11.18 is a ~2:3 mixture of two diastereomers, which we could not separate by silica chromatography. To investigate the scope and limitations, we synthesized a total of 21 examples according to Scheme 3. These examples exemplify some of the diversity of starting materials that can be used in this four-step sequence to provide macrocyclic depsipeptides (Scheme 4). The ring size was modified from 15 to 20. The yields of all reactions are summarized in Table 2 , and interestingly, it was found that they do not depend on the ring sizes. Next, the scope of the Ugi reaction was examined. Two aldehydes 1 and three isocyanides 4 were used to produce five different variations of 5 in good to excellent yields (59-96%, Table 2 ). Next, the investigation of the Passerini cyclization step by using several commercially available aliphatic, aromatic, and heterocyclic oxo components 10 as aldehydes and ketones yielded macrocyclic depsipeptides 11 in low to moderate yield after purification by column chromatography (20-36%, Table 2 ). We found that the presence of the NH 4 Cl additive is necessary for the Passerini ring closure, likely due to the use of the potassium salt in the linkers 9, for neutralization purposes. 
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Educts Yield 5 % tetrazole and the lactone group, as rigid elements which are separated by flexible sp 3 centerbased C1, C3 and C5 chain elements. These linker fragments ultimately will determine the flexibility of the overall macrocyclic conformations in aqueous and lipophilic environments, which will be a determinant of the passive diffusion through cell membranes.
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Figure 2. Representative MCR-derived depsipeptidic 18-membered macrocycle 11.8 in solid state. Above: view on top of the ring plane. Below: Two adjacent antiparallel stacked macrocycles forming two short hydrogen bonds (2 Å, yellow dotted lines) involving secondary amide groups. The flexible elements of the macrocycle in the box are shown in orange. Rendering using PyMol.
Conclusions:
In conclusion, we describe here the first use of the Passerini reaction to close macrocycles and thus form artificial macrocyclic depsipeptides. This is meaningful because macrocyclic depsipeptides are a large group of highly bioactive natural products. The overall sequence used here to introduce different ring sizes and side chain variations is just four steps and using readily available starting materials. Thus, we foresee multiple applications for these artificial macrocycles as unusual scaffolds to target difficult proteinprotein interactions and other postgenomic targets. Libraries of such macrocyclic depsipeptides are currently screened in our laboratory for biological activity and will be reported in due course. This novel method will add to the toolkit of macrocyclizations by MCR. [28] [29] [30] [31] Experimental Section: Procedure and analytical data for N-trityl protected α-aminotetrazoles:
The synthesis of the N-trityl protected α-aminotetrazole was based on a previously published procedure for N-trityl protected α-aminotetrazole. 22 Briefly, aldehyde (1.5 mmol) and tritylamine (1.0 mmol) were suspended in MeOH (1 mL) in a sealed vial with a magnetic stirring bar. The reaction was heated at 100 o C for 15 minutes using microwave irradiation. Then isocyanide (1.0 mmol) and azidotrimethylsilane (1.0 mmol) were added to the reaction mixture and further irradiated at 100 o C for 15 minutes. The solvent was removed under reduced pressure and the residue was purified using flash chromatography (Pet. ether-Ethyl acetate 1:1). (3-phenyl-1-(tritylamino)propyl)-1H-tetrazol-1-yl) 
Procedure and analytical data for N-deprotected α-aminotetrazoles:
The synthesis of the N-deprotected α-aminotetrazole was based on a previously published procedure for N-deprotected α-aminotetrazole. 22 N-trityl protected α-aminotetrazole (0.5 mmol) was dissolved in dichloromethane (2.5 mL) in a vial with a magnetic stirring bar. Trifluoroacetic acid (1.0 mmol, 77 μL) was added dropwise. The reaction was developed for 1 min. and was purified using a silica pad wetted with heptane: EtOAc (1:1). The side product was washed out with heptane: EtOAc (1:1). The Ndeprotected α-aminotetrazole was collected with CH 2 Cl 2 : MeOH (1:1). The solvent was removed under reduced pressure which gave the pure product. 
Procedure and analytical data for the coupling reactions:
A suspension of N-deprotected α-aminotetrazole derivatives (1.0 mmol), potassium isocyanide derivatives (1.2 mmol), and triethylamine (1.0 mmol) in CH 3 CN (10 mL) were stirred for 10 min. at 0 o C, then HOBt (1.0 mmol) and DCC (1.0 mmol) were added to the mixture, the reaction mixture was stirred for 48 h. The insoluble materials were filtered off and the filtrate was evaporated. The residue was purified by column chromatography (Pet. ether-Ethyl acetate 1:4). 
Methyl 3-(5-((6-isocyanohexanamido)methyl)-1H-tetrazol-1-yl)-3-phenylpropanoate 8.14:
The product was obtained as a yellow oil (64%, 0.246 g). 
Methyl 3-(5-((4-isocyanobutanamido)methyl)-1H-tetrazol-1-yl)-3-phenylpropanoate 8.21:
The product was obtained as a yellow oil (73%, 0.259 g). 
General procedure for the saponification reactions:
The isocyanide ester (1.0 mmol) was dissolved in EtOH (1 mL) and potassium hydroxide (1.5 mmol) was added. The reaction was stirred at room temperature. After consumption of the starting material indicated by TLC, the solvent was removed under vacuum and the potassium salt is subjected directly to the next step.
Procedure and analytical data for the macrocyclization reaction:
A Mixture of α-isocyano-ω-carboxylic acid (1.0 mmol) and ammonium chloride (1.5 mmol) in H 2 O (0.01 M, 100 mL) was stirred at room temperature for 30 min., then aldehyde or ketone (1.0 mmol) was added to the reaction mixture and further stirred for 72 h. The solvent was removed under reduced pressure and the residue was purified using flash chromatography (CH 2 Cl 2 : MeOH 9:1). 7,8,9,14,15,16,17,18,19,21,22-Dodecahydro-5H-tetrazolo[5,1-m][1,4,11,14 , 3H), 1.99-1.95 (m, 1H), 1.90-1.86 (m, 3H), 1.75-1.66  (m, 1H), 1.64-1.56 (m,45H), 1.53-1.45 (m, 2H), 1.38-1.31 (m, 4H) . 13 Benzyl-22'-phenethyl-6',7',8',9',14',15',16',17',18' ,19',21',22'- 80 (m, 2H), 1.66-1.55 (m, 4H),1.32-1.23 (m, 2H) . 13 Methylthio)ethyl)-6,7,8,9,14,15,16,17,19,20-decahydro-5H-tetrazolo[5,1-k][1,4,-9,12]oxatriazacyclooctadecine-10,13,-18(12H)-trione (11.11) :
6,

1-
12-(2-(
The product was obtained as a white solid (32%, 0. Chlorophenyl)-6,7,8,9,14,15,16,17,19,20-decahydro-5H-tetrazolo[5,1-k][1,4,9,-12]oxatriazacyclooctadecine-10,13,18-(12H)-trione (11.13) :
12-(4-
The product was obtained as a white solid (21%, 0. Phenyl-5,6,11,12,13,14,15,16,18,19-decahydrotetrazolo[5,1-m][1,4,11,14]oxatriaza  cyclo-heptadecine-7,10,17(9H)trione (11.14) :
5-
The product was obtained as a white solid (28%, 0.112 g, mp 151-153 o C). 1 Phenethyl-6,7,12,13,14,15,17,18-octahydro-5H-tetrazolo-[5,1-k][1,4,9,12 ]oxatriaza cyclohexa-decine-8,11,16(10H)trione (11.17):
18-
The product was obtained as a white solid (29%, 0.120 g, mp 166- Crystal structure determination X-ray diffraction data for single crystals of compounds 5.17, 11.8 and 5.14 were collected using SuperNova (Rigaku -Oxford Diffraction) four-circle diffractometer with a mirror monochromator and a microfocus CuKα radiation source (λ = 1.5418 Å). Additionally, the diffractometer was equipped with a CryoJet HT cryostat system (Oxford Instruments) allowing low-temperature experiments. Single crystals X-ray experiments were performed at 130K and 120 K for 5.17, 11.8 and 5.14, respectively. The obtained data sets were processed with CrysAlisPro software. 23 The phase problem was solved by direct methods using SIR2004. 24 Parameters of obtained models were refined by full-matrix leastsquares on F 2 using SHELXL-2014/6. 25 Calculations were performed using WinGX integrated system(ver. 2014.1). 26 Figures were prepared with Mercury 3.5 software.
27
All non-hydrogen atoms were refined anisotropically. All hydrogen atoms attached to carbon atoms were positioned with the idealized geometry and refined using the riding model with the isotropic displacement parameter U iso [H] = 1.2 (or 1.5 (methyl groups only)) U eq [C] . The position of hydrogen linked to the N atoms was found on the difference Fourier map and refined with no restraints on the isotropic displacement parameter.Crystal data and structure refinement results for presented crystal structures are shown in Table 2 . Asymmetric units are shown in Figure 2 .
Crystallographic data for structures presented in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC1442895 (5.17), CCDC 1442896 (11.8), CCDC 1473836 (5.14). Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, (fax: +44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk). 
